M. Chartier
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Rheumatology 24
- Rheumatoid Arthritis Research and Therapies 19
- Systemic Lupus Erythematosus Research 4
- Genetics 14
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Rieke Alten (25 shared papers)C. Rauch (25 shared papers)H. Nüßlein (19 shared papers)Manuela Le Bars (19 shared papers)Mauro Galeazzi (11 shared papers)Coralie Poncet (15 shared papers)Hanns‐Martin Lorenz (13 shared papers)Xavier Mariette (12 shared papers)
In The Last Decade
M. Chartier
40 papers receiving 329 citations
Peers
Comparison fields: 5 of 46
- Rheumatology 261
- Genetics 42
- Hematology 40
- Pathology and Forensic Medicine 38
- Radiology, Nuclear Medicine and Imaging 36
Countries citing papers authored by M. Chartier
This map shows the geographic impact of M. Chartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Chartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Chartier more than expected).
Fields of papers citing papers by M. Chartier
This network shows the impact of papers produced by M. Chartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Chartier. The network helps show where M. Chartier may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Chartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 41 | |
| 2 | 2017 | 35 | |
| 3 | 2015 | 34 | |
| 4 | Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. | 2016 | 29 |
| 5 | 2019 | 27 | |
| 6 | 2017 | 25 | |
| 7 | 2016 | 16 | |
| 8 | 2016 | 15 | |
| 9 | 2022 | 15 | |
| 10 | 2014 | 11 | |
| 11 | Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease. | 1989 | 10 |
| 12 | 2019 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2012 | 5 | |
| 18 | 2013 | 4 | |
| 19 | 2007 | 4 | |
| 20 | 2019 | 4 |
About M. Chartier
M. Chartier is a scholar working on Rheumatology, Genetics, Pathology and Forensic Medicine, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 340 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Systemic Lupus Erythematosus Research (4 papers), Metabolism and Genetic Disorders (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Rheumatology (261 citations), Genetics (42 citations), Hematology (40 citations), Pathology and Forensic Medicine (38 citations) and Radiology, Nuclear Medicine and Imaging (36 citations). M. Chartier has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include Rieke Alten, C. Rauch, H. Nüßlein, Manuela Le Bars, Mauro Galeazzi, Coralie Poncet, Hanns‐Martin Lorenz, Xavier Mariette, Michael T. Nurmohamed and W. Bensen. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical Rheumatology, Lara D. Veeken, RMD Open and BMC Musculoskeletal Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.